Integra LifeSciences Receives FDA 510(k) Clearance for 3 Spine Devices

Integra LifeSciences has received FDA 510(k) clearance for three new spinal intervertebral body fusion devices, according to a company news release.

Advertisement

The new spinal fixation systems include the Cervical Stand-alone IBD, Vu CPOD Non-Strut IBD and Steerable IBD. The IBDs are small hollow implants that are inserted into intervertebral space to restore physiological disc height and allow fusion between vertebral bodies.

The devices are designed to maintain the natural disc space height and provide positive mechanical stabilization of the vertebrae, which relives pressure on the nerves. The devices’ graft window allows natural bone growth to occur through the IBD.

The devices are currently in limited commercial release and are targeted for full commercial release later this year.

Read the Integra LifeSciences release on the spine devices.

Read other coverage on Integra LifeSciences:

– Integra LifeSciences Launches Integra Allograft Cancellous Sponge


– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment


– Integra LifeSciences Reports $194.1M 4Q Revenue, 6% Increase

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.